/ Print /

Find out about the latest treatment and drug pipeline developments
Managed care organizations may be the next target of value-based reimbursements, with bonus payments tied to the health of their company—and its members.
High drug prices continue to plague payers, but various contributing factors intensify the problem.
Results from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017.
CMS is adding, dropping, and expanding payment rules
Plans and PBMs are finding new ways to rein in pharmacy costs.
Does your analytics team have what it takes? Experts share their top recommendations.
Experts share how Trump could change Obamacare coverage, accessibility, affordability, Medicare/Medicaid, price transparency, and more.
Here’s how you can recognize changes in the oncology pipeline and maximize value related to cancer care.
Here are some of the latest precision medicine approaches being used by managed care organizations, health systems and academic medical centers across the U.S.
Top 3 pharmacy challenges in 2017: ...

Here are three pharmacy challenges facing healthcare executives and a two-pronged solution to help solve them.

Top challenges in cancer care
Watch list 2017: Top therapeutic areas
Top pharmacy challenges of 2017
Six things to know: How health execs ...

Experts discuss how managed healthcare executives might benefit from the ACA repeal and other healthcare reforms.

Four things to know: Payers’ biggest ...
The healthcare industry trend that ...
How Trump will change four major ...
Zika Virus
Top ob/gyn stories of 2016

2016 was a year of change and new challenges. Find out what the top news stories of 2016 were.

Looking back at 2016
New Products: Test launched to ...
Zika effects are more than ...

Latest Issue

Find us on Facebook

Follow Us On Twitter

Latest Tweets Follow